Literature DB >> 24975353

High tuberculosis treatment success in Kabul, Afghanistan despite high patient transfers out.

M Zhuben, F M Delawer, A H Andar, F Salimi, J Ngamvithayapong-Yanai.   

Abstract

The National Tuberculosis (TB) Institute has the highest patient transfer-out rate in Afghanistan, but the result and treatment outcome of transferred patients were unknown in 2009. This operational research investigated the characteristics and treatment outcome of all transferred-out patients living in Kabul province. We analysed the 1-year TB register of the Institute (n = 1180 cases) and visited 24 health centres to review their TB registers. The results show the transfer-out rate was 52.6%. Of the transferred cases, 58.6% were women and 61.8% pulmonary TB cases (smear-positive 70.6%). The arrival rates of transfer-out patients at health centres in Kabul province were 87.6% for both men and women. Males aged 21-40 years were the most likely to be nonarrivals (OR = 8.91; 95% CI: 1.55-66.7). Treatment success rates in female and male patients were 84.4% and 77.5% respectively and default rates were 7.8% and 18.3%. Strategies to reduce the non-arrival to health centres and treatment interruption in male patients aged 20-40 years are warranted.

Entities:  

Mesh:

Year:  2013        PMID: 24975353

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

Review 1.  Transfer of primary care patients receiving chronic care: the next step in the continuum of care.

Authors:  Jasantha Odayar; Landon Myer
Journal:  Int Health       Date:  2019-11-13       Impact factor: 2.473

2.  Characteristics and Treatment Outcomes of "Transfer-Out" Pulmonary Tuberculosis Patients in Gondar, Ethiopia.

Authors:  Tadesse Belayneh; Afework Kassu; Desalgne Tigabu; Gashaw Asmare; Sofanit Tilaye; Eveline Klinkenberg
Journal:  Tuberc Res Treat       Date:  2016-05-30

3.  Addressing tuberculosis control in fragile states: Urban DOTS experience in Kabul, Afghanistan, 2009-2015.

Authors:  G Qader; A Hamim; M Sayedi; M Rashidi; L Manzoor; M K Seddiq; N Ikram; P G Suarez
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.